Foresight Biotherapeutics

Pioneering New Therapies to Address Significant Unmet Needs in Ophthalmology and Otolaryngology. Foresight's Povidone-Iodine (PVP-I) Platform Technology Represents an Important Breakthrough in the Treatment of Ocular and Ear Inflammation, Including Bacterial, Viral, and Fungal Infections. The platform allows PVP-I, a well-characterized broad-spectrum antimicrobial agent with no known microbial resistance, to be formulated alongside a range of anti-inflammatory agents.